These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 21981386

  • 1. Hepatitis B virus transmission by blood transfusion during 4 years of individual-donation nucleic acid testing in South Africa: estimated and observed window period risk.
    Vermeulen M, Dickens C, Lelie N, Walker E, Coleman C, Keyter M, Reddy R, Crookes R, Kramvis A.
    Transfusion; 2012 Apr; 52(4):880-92. PubMed ID: 21981386
    [Abstract] [Full Text] [Related]

  • 2. Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program.
    Satake M, Taira R, Yugi H, Hino S, Kanemitsu K, Ikeda H, Tadokoro K.
    Transfusion; 2007 Jul; 47(7):1197-205. PubMed ID: 17581154
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
    Hourfar MK, Jork C, Schottstedt V, Weber-Schehl M, Brixner V, Busch MP, Geusendam G, Gubbe K, Mahnhardt C, Mayr-Wohlfart U, Pichl L, Roth WK, Schmidt M, Seifried E, Wright DJ, German Red Cross NAT Study Group.
    Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy of hepatitis B virus (HBV) DNA screening and characterization of acute and occult HBV infections among blood donors from Madrid, Spain.
    González R, Torres P, Castro E, Barbolla L, Candotti D, Koppelman M, Zaaijer HL, Lelie N, Allain JP, Echevarría JM.
    Transfusion; 2010 Jan; 50(1):221-30. PubMed ID: 19682332
    [Abstract] [Full Text] [Related]

  • 7. Reduction of the risk of transfusion-transmitted viral infection by nucleic acid amplification testing in the Western Cape of South Africa: a 5-year review.
    Cable R, Lelie N, Bird A.
    Vox Sang; 2013 Feb; 104(2):93-9. PubMed ID: 22924987
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Residual risk of transfusion-transmitted hepatitis B virus (HBV) infection caused by blood components derived from donors with occult HBV infection in Japan.
    Taira R, Satake M, Momose S, Hino S, Suzuki Y, Murokawa H, Uchida S, Tadokoro K.
    Transfusion; 2013 Jul; 53(7):1393-404. PubMed ID: 23033944
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A revised method for estimating hepatitis B virus transfusion residual risk based on antibody to hepatitis B core antigen incident cases.
    Laperche S, Maniez M, Barlet V, El Ghouzzi MH, Le Vacon F, Levayer T, Lunel F, Morel P, Mouillot L, Piquet Y, Pillonel J, Transfusion-Transmissible Agents Working Group, French National Society of Blood Transfusion.
    Transfusion; 2008 Nov; 48(11):2308-14. PubMed ID: 18673347
    [Abstract] [Full Text] [Related]

  • 15. Enhanced detection of hepatitis B virus in Hong Kong blood donors after introduction of a more sensitive transcription-mediated amplification assay.
    Tsoi WC, Lelie N, Lin CK.
    Transfusion; 2013 Oct; 53(10 Pt 2):2477-88. PubMed ID: 23521050
    [Abstract] [Full Text] [Related]

  • 16. Occult hepatitis B virus infection: implications in transfusion.
    Allain JP.
    Vox Sang; 2004 Feb; 86(2):83-91. PubMed ID: 15023176
    [Abstract] [Full Text] [Related]

  • 17. Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience.
    O'Brien SF, Fearon MA, Yi QL, Fan W, Scalia V, Muntz IR, Vamvakas EC.
    Transfusion; 2007 Oct; 47(10):1809-15. PubMed ID: 17880605
    [Abstract] [Full Text] [Related]

  • 18. Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009.
    Al Shaer L, AbdulRahman M, John TJ, AlHashimi A.
    Transfusion; 2012 Nov; 52(11):2300-9. PubMed ID: 22691239
    [Abstract] [Full Text] [Related]

  • 19. Lengths of hepatitis B viremia and antigenemia in blood donors: preliminary evidence of occult (hepatitis B surface antigen-negative) infection in the acute stage.
    Yoshikawa A, Gotanda Y, Minegishi K, Taira R, Hino S, Tadokoro K, Ohnuma H, Miyakawa K, Tachibana K, Mizoguchi H, Japanese Red Cross NAT Screening Research Group.
    Transfusion; 2007 Jul; 47(7):1162-71. PubMed ID: 17581150
    [Abstract] [Full Text] [Related]

  • 20. Detection of occult hepatitis B and window period infection among blood donors by individual donation nucleic acid testing in a tertiary care center in South India.
    Keechilot CS, Shenoy V, Kumar A, Biswas L, Vijayrajratnam S, Dinesh K, Nair P.
    Pathog Glob Health; 2016 Jul; 110(7-8):287-291. PubMed ID: 27788631
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.